Assessment of Macular Microvascular Changes after Intravitreal Ranibizumab Injection in Diabetic Macular Edema | ||
| International Journal of Medical Arts | ||
| Article 3, Volume 5, Issue 10, October 2023, Pages 3693-3700 PDF (1.11 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ijma.2023.242815.1840 | ||
| Authors | ||
| Asmaa Abdallah Abd-Elnaby* ; Jihan Abdallah Mohamed; Mona Mohamad Aly | ||
| Department of Ophthalmology, Faculty of Medicine [for girls], Al-Azhar University, Cairo, Egypt | ||
| Abstract | ||
| Objective: With the help of optical coherence tomography angiography, this study sought to determine if the retinal capillary plexus and choriocapillaris in diabetic macular edema patients' eyes had changed after Ranibizumab is administered intravitreally once. Patients and Methods: A prospective, interventional, randomized clinical trial with 20 diabetic macular edema patients' eyes were chosen from outpatient clinic Ophthalmology department of Al-Azhar university hospital, Cairo, Egypt during period from 2022 to 2023. Prior to intravitreal ranibizumab treatment and one month after, the visual acuity of each patient was assessed. Optical Coherence Tomography Angiography was performed at baseline preoperatively and 1 month postoperatively for assessing superficial capillary plexus, deep capillary plexus, vascular density, Foveal avascular zone, and choriocapillaris vessels density. Results: The BCVA showed a considerable improvement [p <0.001] and significant reduction in the CFT [p value < 0.001]. Also, choriocapillaris showed a significant improvement [p value < 0.001]. On the other hand, there were in significant changes in the superficial capillary plexus, deep capillary plexus, vascular density, and Foveal avascular zone before and after treatment. Conclusion: Intravitreal ranibizumab effectively decreased macular thickness and improved visual acuity and choriocapillaris. | ||
| Keywords | ||
| Retinal capillary plexus; Choriocapillaris; Optical coherence tomography angiography; Intravitreal; Ranibizumab | ||
|
Statistics Article View: 146 PDF Download: 123 |
||
